Patents by Inventor Valérie COSSON

Valérie COSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220370447
    Abstract: The present invention relates to method of treating HBV infection in a human patient, wherein the method comprises administration of a therapeutically effective amount of Compound (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: November 24, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Qingyan BO, Valérie COSSON, Sheng FENG, Lu GAO, Yuyan JIN, Annabelle LEMENUEL, Miriam TRIYATNI, Xue ZHOU, Mingfen ZHU
  • Publication number: 20210079103
    Abstract: The invention provides dosage regimes for treatment of synucleinopathies. In one regime, a subject receives 3000-5000 mg of an antibody intravenously every 3-5 weeks. In another regime, a subject receives 1300-1700 mg of an antibody intravenously every 3-5 weeks.
    Type: Application
    Filed: July 23, 2020
    Publication date: March 18, 2021
    Inventors: Jay Soto, Daniel Keith Ness, Martin Koller, Diane Mould, Frank Boess, Meret Martin-Facklam, Valerie Cosson, Hans Peter Grimm, Ronald Gieschke, Sara Belli, Silke Weber
  • Publication number: 20190153102
    Abstract: The invention provides dosage regimes for treatment of synucleinopathies. In one regime, a subject receives 3000-5000 mg of an antibody intravenously every 3-5 weeks. In another regime, a subject receives 1300-1700 mg of an antibody intravenously every 3-5 weeks.
    Type: Application
    Filed: September 28, 2018
    Publication date: May 23, 2019
    Inventors: Jay Soto, Daniel Keith Ness, Martin Koller, Diane Mould, Frank Boess, Meret Martin-Fracklam, Valerie Cosson, Hans Peter Grimm, Ronald Gieschke, Sara Belli, Silke Weber